Avricore Health (AVCRF) Net Income towards Common Stockholders (2009 - 2026)
Avricore Health (AVCRF) posted quarterly Net Income towards Common Stockholders of -$174490.3 for Q2 2026, up 47.33% year-over-year from -$118437.3 in Q2 2025, and up 45.67% quarter-over-quarter from -$321177.9 in Q4 2025.
Avricore Health (AVCRF) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends
Avricore Health (AVCRF) has reported Net Income towards Common Stockholders for 18 consecutive years, with -$174490.3 the latest figure, recorded in Q2 2026.
- In Q2 2026, Net Income towards Common Stockholders rose 47.33% year-over-year to -$174490.3; the TTM figure through Jun 2026 stood at -$771272.2 (down 49.23% YoY), while the FY2025 annual figure was -$1.3 million, down 172.28% from the prior year.
- Net Income towards Common Stockholders advanced to -$174490.3 in Q2 2026 per AVCRF's latest filing, from -$321177.9 in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $163943.0 in Q2 2024 and bottomed at -$331271.8 in Q2 2025.
- Historically, Net Income towards Common Stockholders has averaged -$133598.0 across 5 years, with a median of -$154930.3 in 2022.
- Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders slumped 1514.8% — and 2024, when it surged 187.48%.
- Avricore Health's Net Income towards Common Stockholders stood at -$174323.1 in 2022, then surged by 129.31% to $51100.9 in 2023, then sank by 357.63% to -$131651.8 in 2024, then plunged by 143.96% to -$321177.9 in 2025, then jumped by 45.67% to -$174490.3 in 2026.
- Business Quant data shows AVCRF's Net Income towards Common Stockholders at -$174490.3 in Q2 2026, -$321177.9 in Q4 2025, and -$275603.9 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 1.76 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 870.00 Mn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -66.93 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 339.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 241.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 338.41 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 207.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 232.90 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 299.10 Mn |
| 10 | Avricore Health | 3.04 Mn | 3.01 Mn | -6.20 Bn | -174,490.30 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -174,490.30 |
| Dec 31, 2025 | -315,423.31 |
| Sep 30, 2025 | -271,448.31 |
| Jun 30, 2025 | -338,704.01 |
| Mar 31, 2025 | -52,333.55 |
| Sep 30, 2024 | -128,132.60 |
| Jun 30, 2024 | 155,398.81 |
| Mar 31, 2024 | 117,586.35 |
| Dec 31, 2023 | -515,592,522.52 Bn |
| Sep 30, 2023 | 195.27 Bn |
| Jun 30, 2023 | -211,529.47 |
| Mar 31, 2023 | -142,972.21 |
| Dec 31, 2022 | -212.13 Bn |
| Sep 30, 2022 | 165,587,285.90 Bn |
| Jun 30, 2022 | 44,608,590.34 Bn |
| Mar 31, 2022 | -146,723.21 |
| Dec 31, 2021 | -27,730.29 |
| Sep 30, 2021 | 16.33 Bn |
| Jun 30, 2021 | -811.94 Mn |
| Mar 31, 2021 | 1.30 Bn |